Clinical Trials
34 trialsNCT06885424 2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
NCT04981119 2026-04-30
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
NCT05520099 2026-04-29
ELEPHAS-02
Elephas
Active not recruiting
NCT05858749 2026-02-27
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Pfizer
Completed
NCT05366881 2026-01-20
CAMPERR
Adela, Inc
Recruiting
NCT07327489 2026-01-08
ELEPHAS-05
Elephas
Recruiting
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT04825834 2025-08-08
DELFI-L101
Delfi Diagnostics Inc.
Completed
NCT06264479 2025-07-30
PEAR-TREE2
Ourotech, Inc.
Terminated
NCT03455452 2025-06-25
WITNESS
Bristol-Myers Squibb
Active not recruiting
NCT05179824 2025-05-06
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Active not recruiting
NCT04889495 2025-03-19
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Pfizer
Withdrawn
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT05363072 2024-10-01
A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.
Pfizer
Completed
NCT03133286 2024-08-07
RADIANT
DxTerity Diagnostics
Completed
NCT04669366 2024-07-19
Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries
Pfizer
Completed
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT01117779 2024-01-19
TRACE
Boston Scientific Corporation
Terminated
NCT04329767 2023-09-29
A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Surgical Planning and Intra-operative Navigation for Nephrectomy
Intuitive Surgical
Completed
NCT02609269 2023-02-17
GRID®
GenomeDx Biosciences Corp
Enrolling by invitation
NCT03568435 2022-10-20
Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants
Bristol-Myers Squibb
Completed
NCT03662204 2022-09-01
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Exact Sciences Corporation
Completed
NCT04472663 2022-04-26
Participant Reported Outcomes and Treatment Experiences in Kidney Cancer
Bristol-Myers Squibb
Completed
NCT04869462 2022-04-12
DOSTILCU
Aesculap AG
Completed
NCT03663946 2022-02-25
A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread
Bristol-Myers Squibb
Completed
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT03606044 2020-02-12
3D Virtual Models as an Adjunct to Preoperative Surgical Planning
Innersight Labs Ltd
Completed
NCT01236053 2017-07-06
Cancer in Patients With Gabapentin (GPRD)
GlaxoSmithKline
Completed
NCT01138124 2017-05-30
Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)
GlaxoSmithKline
Completed
NCT01444456 2017-03-20
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Completed
NCT02143492 2017-01-24
Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC
Argos Therapeutics
Completed
NCT00836745 2013-12-20
Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent
Pfizer
Completed
NCT00873210 2012-11-09
Study In Patients With Kidney Cancer Treated With Sutent
Pfizer
Completed
NCT00460798 2010-11-16
SUNIKA
Pfizer
Completed